Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Asieris, Aslan Pharmaceuticals, Atom Bioscience, Carsgen Therapeutics, Foresee Pharmaceuticals, Genfleet, Hanall Biopharma, I-Mab Biopharma, Innovent Biologics, Meiji Seika Pharm, Samsung Bioepis, Shionogi, Sun Pharmaceutical.